Christopher Dinsmore, Chief Scientific Officer at Kronos Bio, Inc. (KRON), sold 9,138 shares at $1.81 ($17K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Open-market sale of $17k KRON by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRON | SELL | 2023-07-07 | $12K | — | Filing → |
| KRON | SELL | 2023-02-24 | $11K | — | Filing → |
| KRON | SELL | 2021-12-15 | $279K | — | Filing → |